Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
13 /100
LOW RISK
Score updated Oct 13, 2026

ARWR — Arrowhead Pharmaceuticals, Inc. Dilution Risk Tracker

Track ARWR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARWR — Get alerts when the score changes →

As of October 13, 2026, Arrowhead Pharmaceuticals, Inc. (ARWR) has a DilutionWatch DilutionScore of 13/100, rated LOW dilution risk. Arrowhead Pharmaceuticals, Inc. has a market capitalization of $8.86B, 141.25M shares outstanding, 441 institutional holders tracked. Stored dilution-related fields include 80.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
22
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄 Convertible Debt
35

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
🔁 Convertible Conversion model 15%
• Convertible debt present: 7.9% potential dilution
🔔 Track ARWR — Get forecast alerts →

Market Data

Market Cap$8.86B
Shares Outstanding141.25M
Float122.78M
Cash$1.66B
Debt$1.38B
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore13/100DilutionWatch score record
Shares Outstanding141.25MVerified float table or market cache
Public Float122.78MVerified float table or market cache
Market Cap$8.86BMarket data cache
Cash Runway61.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants80.0KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 3.

Recent SEC source mix: 4 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 25.8% shares (2026Q1 vs prior)
441 institutional holders · 152.53M shares
#1 Avoro Capital Advisors LLC 21.32M shares
#2 BlackRock, Inc. 18.16M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 12.06M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest10.76M
Days to Cover4.0
% of Float8.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-08-04
xbrl XBRL WARRANT 2026-08-04
4 INSIDER TRANSACTION 2026-03-09
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ARWR Dilution Snapshot

Arrowhead Pharmaceuticals, Inc. (ARWR) has a DilutionScore of 13/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ARWR's DilutionScore is currently 13/100 (Low risk), with 4 score changes tracked over 89 days. The score deteriorated from 16/100 (Low risk).

Period Score Risk Level Duration
Sep 19 – Oct 13, 202613/100LOW25 days
Sep 15 – Sep 18, 202616/100LOW4 days
Aug 22 – Sep 14, 202613/100LOW24 days
Aug 14 – Aug 21, 202610/100LOW7 days
Jul 16 – Aug 13, 202613/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ARWR shares outstanding have increased 0.6% from 140.03M (Apr 2026) to 140.86M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 2026140.86M122.78M▼ 0.03%
May 19, 2026140.86M122.81M▼ 0.04%
May 16, 2026140.86M122.86M▲ 0.09%
May 10, 2026140.86M122.76M▲ 0.59%
Apr 28, 2026140.03M122.04M▼ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ARWR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ARWR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ARWR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ARWR
ARWR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.